Livzon Pharmaceutical Group Financial Overview
Livzon Pharmaceutical Group's market cap is currently HK$31.85B. The company's EPS TTM is HK$0.5725932628; its P/E ratio is 11.21; and it has a dividend yield of 4.12%. Livzon Pharmaceutical Group is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is HK$0.46. See an overview of income statement, balance sheet, and cash flow financials.
